Pelvic Inflammatory Disease in COVID-19 Era

NCT05648747 | Unknown DMC

• 1 other identifier: 826/2022/Oss/AOUFe
• Study Type: observational
• Target: 300
• Locations: 1 country
• Sites: 1

Brief Summary

The goal of this retrospective cohort study is to to scrutinize the impact of coronavirus disease 2019 (COVID-19) on incidence, demography and patient characteristics in Pelvic Inflammatory Disease comparing with the equal time duration, before and after lockdown was initiated in the country. The main aim of this study was to compare the demographic and clinical parameters between two cohorts before the onset of lockdown and within the pandemic.

Conditions

Pelvic Inflammatory Disease

Outcome Measures

Primary Outcomes (1)

• Incidence of pelvic inflammatory disease (PID)

  The primary outcome measure was the occurrence of PID defined as abscess observed in computed tomography or a description of gangrenous salpingitis assessed by pathological reports.

  baseline, pre-surgery

Study Arms (2)

Complicated Pelvic Inflammatory Disease

The development of complicated Pelvic Inflammatory Disease diagnosed during laparoscopy or by pre-operative image study

Other: impact of COVID-19 on Health-Seeking Behaviors

Non-Complicated Pelvic Inflammatory Disease

No development of complicated Pelvic Inflammatory Disease diagnosed during laparoscopy or by pre-operative image study

Other: impact of COVID-19 on Health-Seeking Behaviors

Interventions

impact of COVID-19 on Health-Seeking Behaviors OTHER

The impact of the coronavirus disease 2019 (COVID-19) pandemic on medical services is overwhelming due to limited medical resources. During its initial surge in 2020, Italy's government rapidly established diverse public actions, which helped maintain the medical supply. However, whether the fear of being infected with COVID-19 interfered with health-seeking behavior (HSB) remains unclear. Therefore, this study aimed to elucidate whether pelvic inflammatory disease rates were affected by the COVID-19 pandemic.

Complicated Pelvic Inflammatory Disease; Non-Complicated Pelvic Inflammatory Disease

Eligibility Criteria

• Age: 18 Years+
• Sex: female
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

A retrospective analysis of pelvic inflammatory disease in women was performed between March 8, 2020 and March 31, 2022 (COVID-19 period). The control period was collected between January , 2020 and December 31, 2019.

You may qualify if:

• Pelvic Inflammatory disease

You may not qualify if:

• Pregnancy Oncologic disease

Sponsors & Collaborators

• Università degli Studi di Ferrara: lead

Study Sites (1)

Section of Obstetrics and Gynecology, Department of Morphology, Surgery and Experimental Medicine, University of Ferrara, Ferrara, Italy

Ferrara, Italy

RECRUITING

MeSH Terms

Conditions

Pelvic Inflammatory Disease

Condition Hierarchy (Ancestors)

Pelvic Infection; Infections; Adnexal Diseases; Genital Diseases, Female; Female Urogenital Diseases; Female Urogenital Diseases and Pregnancy Complications; Urogenital Diseases; Genital Diseases

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: MD

Study Record Dates

• First Submitted: December 9, 2022
• First Posted: December 13, 2022
• Study Start: January 1, 2023
• Primary Completion: January 1, 2024
• Study Completion: January 30, 2024
• Last Updated: December 13, 2022

Record last verified: 2022-12

Data Sharing

• IPD Sharing: Will not share

Locations

IT (1)